60
Participants
Start Date
December 1, 2023
Primary Completion Date
February 28, 2026
Study Completion Date
June 30, 2026
Baricitinib 4 MG
1 capsule (4mg) daily for 24 weeks
Placebo
1 capsule daily
RECRUITING
The Chinese University of Hong Kong, Hong Kong
Chinese University of Hong Kong
OTHER